CYTK
Biotechnology · Healthcare
Head of Investor Relations
Head of Investor Relations
Cytokinetics Inc (CYTK)Equibles does not estimate personal net worth.
Get an email with a short summary when Cytokinetics Inc publishes a filing, an earnings call transcript or a press release.
Get CYTK alertsDiane Weiser is recorded as Head of Investor Relations at Cytokinetics Inc (CYTK). Diane Weiser has spoken on 18 earnings calls across 1 company, most recently for Cytokinetics Inc on November 4, 2026. Cytokinetics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cytokinetics Inc includes Robert Blum (CEO), Robert I. Blum (CEO and Board Member), John T. Henderson, M.D. (Chairman) and 7 others.
“The slides accompanying today's webcast can be found on the Investors and Media section of our website at cytokinetics.com, along with today's press release. Robert Blum, President and Chief Executive Officer, will begin with an overview of the quarter and recent developments.”
“The slides accompanying today's webcast can be found on the Investors and Media section of our website at cytokinetics.com, along with today's press release. Robert Blum, President and Chief Executive Officer, will begin with an overview of the quarter and recent developments.”
“Robert Blum, President and Chief Executive Officer, will begin with an overview of the quarter and recent development. Andrew Kalos, EVP and Chief Commercial Officer, will discuss the commercial launch of a Micorzo in the U.S. and readiness in Europe.”
“Robert Blum, President and Chief Executive Officer, will begin with an overview of the quarter and recent developments. Andrew Kalos, EVP and Chief Commercial Officer, will discuss the commercial launch of Micorzo in the U.S. and readiness in Europe.”
“Robert Blum, President and Chief Executive Officer, will begin with an overview of the quarter and recent developments. Andrew Kalos, EVP and Chief Commercial Officer, will address commercial readiness activities for AFI-Campton.”
CYTK
Biotechnology · Healthcare
Head of Investor Relations